MRC Centre for Global Infectious Disease Outbreak Analysis, Imperial College London, London, UK.
Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Nat Rev Microbiol. 2022 Sep;20(9):557-571. doi: 10.1038/s41579-022-00720-1. Epub 2022 Mar 29.
Invasive fungal infections pose an important threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a period of profound global environmental change and expanding at-risk populations, human-infecting pathogenic fungi are evolving resistance to all licensed systemic antifungal drugs. In this Review, we highlight the main mechanisms of antifungal resistance and explore the similarities and differences between bacterial and fungal resistance to antimicrobial control. We discuss the research and innovation topics that are needed for risk reduction strategies aimed at minimizing the emergence of resistance in pathogenic fungi. These topics include links between the environment and One Health, surveillance, diagnostics, routes of transmission, novel therapeutics and methods to mitigate hotspots for fungal adaptation. We emphasize the global efforts required to steward our existing antifungal armamentarium, and to direct the research and development of future therapies and interventions.
侵袭性真菌感染对公众健康构成重大威胁,也是人们尚未充分认识到的抗菌药物耐药性的一个组成部分,这是全球范围内正在出现的一个危机。在全球环境发生深刻变化和受威胁人群不断扩大的时期,导致人类感染的致病性真菌正在对所有已许可的全身性抗真菌药物产生耐药性。在这篇综述中,我们重点介绍了抗真菌耐药性的主要机制,并探讨了细菌和真菌对抗菌药物控制产生耐药性的异同。我们讨论了为旨在尽量减少致病性真菌产生耐药性的风险降低策略所需的研究和创新主题。这些主题包括环境与“同一健康”之间的联系、监测、诊断、传播途径、新的治疗方法以及减轻真菌适应热点的方法。我们强调了管理现有抗真菌武器库以及指导未来治疗和干预措施的研发所需的全球努力。